Physician

Laura B Van Why, MD

According to 2025 Medicare claims, Laura Why, MD (NPI: 1932132107) practices dermatology in the Fond du Lac, WI market, with the plurality of this provider's patient population coming from Fond Du Lac, WI. This provider's primary affiliated billing organization is AGNESIAN HEALTHCARE INC (NPI: 1730162991; TIN: 390807236) and primary practice location at 54935-3423. Why is affiliated with the SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Why's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 317 traditional Medicare patients, billed 1,587 HCPCS/CPT codes, and received $73,510 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 976 prescription claims across 408 beneficiaries totaling $212,009 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 8 records totaling $270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $61,327 to $212,009. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	470	2,536	$99,301
2016	484	2,562	$96,658
2017	548	2,668	$100,962
2018	527	2,512	$98,227
2019	520	2,503	$102,284
2020	470	2,160	$93,773
2021	525	2,379	$105,758
2022	537	2,556	$104,429
2023	484	2,151	$87,184
2024	317	1,587	$73,510

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	575	$61,327
2016	246	615	$58,593
2017	246	545	$54,099
2018	273	601	$48,717
2019	293	590	$69,040
2020	267	627	$95,874
2021	438	1,004	$148,801
2022	408	1,023	$160,926
2023	431	1,153	$431,320
2024	408	976	$212,009

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	113	113	$67
17110	Destruction of skin growth, 1-14 growths	61	69	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	113	149	$61
17000	Destruction of precancer skin growth, 1 growth	132	158	$37
17003	Destruction of precancer skin growth, 2-14 growths	95	463	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	235	5,801	$9,632
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	52	1,151	$2,683
Fluorouracil	Fluorouracil	34	840	$2,562
Doxycycline Monohydrate	Doxycycline Monohydrate	32	1,574	$1,510
Metronidazole	Metronidazole	19	625	$1,347

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$270	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura B. Van Why, MD?

Tedicare shows public-source Medicare data for Laura B. Van Why, MD (NPI 1932132107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura B. Van Why, MD have ACO affiliation data?

Laura B. Van Why, MD is shown with ACO affiliation data for SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Laura B. Van Why, MD?

Laura B. Van Why, MD is linked to AGNESIAN HEALTHCARE INC (billing NPI 1730162991) in the available physician profile data.

Does Laura B. Van Why, MD have Open Payments data?

Laura B. Van Why, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.